Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7,057	6,412	6,276	1,692	1,334	15,306
Short-Term Investments	-	-	472.52	1,494	-	-
Cash & Short-Term Investments	7,057	6,412	6,748	3,187	1,334	15,306
Cash Growth	17.04%	-4.98%	111.78%	138.79%	-91.28%	71.54%
Accounts Receivable	1,209	2,029	2,452	2,803	724.02	205.04
Other Receivables	10.49	12.69	2.82	5.42	5.98	4.15
Receivables	1,219	2,041	2,455	2,808	1,330	209.19
Inventory	1,011	992.77	921.32	1,746	1,982	602.35
Prepaid Expenses	19.48	5.71	6.03	8.07	57.1	7.76
Other Current Assets	202.05	27.7	14.03	17.24	52.83	33.04
Total Current Assets	9,509	9,480	10,144	7,767	4,756	16,158
Property, Plant & Equipment	8,881	9,015	8,687	9,765	10,948	7,997
Long-Term Investments	-	-	-	-	-0	-0
Other Intangible Assets	12.11	13.47	21.76	71.88	80.62	58.36
Long-Term Deferred Charges	-	-	-	-	636.91	552.08
Other Long-Term Assets	0.08	0.2	0.2	100.28	1,503	52.32
Total Assets	18,402	18,509	18,853	17,704	17,924	24,817

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	294.74	79.34	260.14	239.75	139.18	47.85
Accrued Expenses	424.26	422.74	445.89	521.74	485.06	337.31
Short-Term Debt	-	-	-	5,309	4,583	7,401
Current Portion of Leases	-	-	92.62	288.27	1,089	7.5
Other Current Liabilities	187.21	373.18	287.53	4,854	1,651	6,185
Total Current Liabilities	906.22	875.26	1,086	11,213	7,947	13,979
Long-Term Leases	-	-	-	-	288.27	-
Pension & Post-Retirement Benefits	258.99	225.65	105.69	227.73	60.19	1.17
Other Long-Term Liabilities	-	-	-	43.52	63.44	41.17
Total Liabilities	1,165	1,101	1,192	11,484	8,359	14,022

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4,529	4,529	4,529	3,742	3,420	3,171
Additional Paid-In Capital	42,313	42,313	42,313	35,585	32,955	31,407
Retained Earnings	-28,516	-28,345	-28,092	-32,419	-25,900	-22,872
Comprehensive Income & Other	-1,089	-1,089	-1,089	-688.68	-910.12	-910.12
Shareholders' Equity	17,237	17,408	17,661	6,220	9,565	10,796
Total Liabilities & Equity	18,402	18,509	18,853	17,704	17,924	24,817

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	92.62	5,597	5,960	7,409
Net Cash (Debt)	7,057	6,412	6,656	-2,410	-4,625	7,897
Net Cash Growth	17.04%	-3.66%	-	-	-	109.09%
Net Cash Per Share	780.57	707.85	773.38	-330.86	-702.78	1273.53
Filing Date Shares Outstanding	9.06	9.06	9.06	7.48	6.84	6.34
Total Common Shares Outstanding	9.06	9.06	9.06	7.48	6.84	6.34
Working Capital	8,603	8,605	9,058	-3,446	-3,191	2,179
Book Value Per Share	1902.82	1921.69	1949.65	831.11	1398.45	1702.42
Tangible Book Value	17,225	17,395	17,640	6,148	9,485	10,737
Tangible Book Value Per Share	1901.48	1920.20	1947.25	821.51	1386.67	1693.21
Land	-	3,041	3,041	3,041	3,041	3,041
Buildings	-	3,568	3,568	3,568	3,568	3,568
Machinery	-	4,080	3,194	3,008	2,206	1,565
Construction In Progress	-	11.74	78	268	545.59	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error